302 Research Site 17 — Fleming Island, Florida

302 Research Site 17 is a clinical research site located in Fleming Island, Florida, United States 32003.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

302 Research Site 17 has participated in 1 clinical trials.

Therapeutic areas: Colonoscopy.

Sponsors: Braintree Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fleming Island

Browse all research sites in Florida · View every site in Fleming Island

• Northeast Research Institute
• Fleming Island Center for Clinical Research
• Research Site
• Cancer Specialists of North Florida
• Novo Nordisk Investigational Site
• Florida Cancer Specialists
• Florida Cancer Specialists & Research Institute
• GSK Investigational Site
• Clinical Trial Site
• Cancer Specialists of North Florida-Fleming Island
• Lexicon Investigational Site
• Fleming Island Center For Clinical Research - ERN-PPDS

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 302 Research Site 17?

302 Research Site 17 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 302 Research Site 17 conducted?

302 Research Site 17 has 1 clinical trials on record. Their work covers Colonoscopy.

Is 302 Research Site 17 accredited by Crixeo Clinical Trials?

302 Research Site 17 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 302 Research Site 17?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.